Drug companies report on a new class of Alzheimer's drugs that may slow cognitive decline in the earliest stages of Alzheimer's. The drugs can work on the proteins that cause plaque buildup in the brain, researchers say.
Drug companies report on a new class of Alzheimer's drugs that may slow cognitive decline in the earliest stages of Alzheimer's. The drugs can work on the proteins that cause plaque buildup in the brain, researchers say.